Scarlet fever epidemics have reemerged in China, the UK, and Hong Kong. This research tests whether scarlet fever epidemics in Hong Kong are linked to varicella epidemics.
The relationship between varicella (chickenpox) and scarlet fever in contemporary Hong Kong Introduction This research examines whether recent scarlet fever epidemics in Hong Kong may be linked to varicella. Varicella is a known risk factor for invasive Group A Streptococcal (GAS) infections, such as toxic shock syndrome and necrotizing fasciitis. 1 The possibility of an association between scarlet fever (a GAS infection) and varicella is also indicated by a review of historical case studies linking scarlet fever to varicella in the late 19 th century and by statistical analysis that shows a strong association between the two diseases in the early 20 th century in four American cities-Boston, Chicago, New York, and Philadelphia. 2 The likelihood of a connection between the two diseases is increased because the two diseases attack children in about the same age range, from four to ten years old. As scarlet fever epidemics have unexpectedly returned in several countries, including China 3,4 and the UK 5 , the question is whether there is once again a connection between varicella and scarlet fever. Prior research does not give a definitive answer, however, as to the nature of this relationship; for example, there may be a causal link or a propensity to co-infections or both. The possibility of a relationship also depends on the vaccination rate for varicella.
Methods
In this analysis the association between varicella and scarlet fever is investigated in the period 2011 to 2015 in Hong Kong using monthly reported cases of the two diseases. The main research question in the pre/post analysis is whether the emergence of scarlet fever in 2011 changed the ongoing pattern of annual varicella cycles. Or did the emerging scarlet fever epidemics develop in correspondence to the pre-existing annual varicella cycles?
Results
The first part of the analysis concerns the years from 2011 to 2015 when scarlet fever reemerged on a larger scale. Preliminary regression analysis showed that scarlet fever cases in January and February of 2011 were outliers in the model. That is, these two months belonged in the pre-scarlet fever era. So the analysis of scarlet fever begins with For every 100 cases of varicella, there are about 16 cases of scarlet fever with 95% confidence interval [8, 24] . The significance level for V is p < .0001; for T, p = .003, indicating a decreasing trend in scarlet fever, after controlling for annual changes. All dummy variables for years are positive and statistically significant (p < .01); that is, there are substantial year-to-year changes in average scarlet fever counts independently of varicella and the decreasing trend. A varicella term with one month lag was tried in the model, but it was not statistically significant.
In the pre/post scarlet fever analysis, the time period is divided at February 2011, which ends the pre-scarlet fever period. Statistical comparison of varicella case numbers in the two periods is based on a t-test of means and a Kolmogorov-Smirnov (K-S) nonparametric test of inequality between cumulative distributions. The tests show no statistically significant difference between mean varicella cases per month in the pre-and post-scarlet fever periods (t-test t = 0.04, difference in means 2.8, p = .97), and no difference in the pre/post cumulative distributions (K-S test, p = 0.76). There also does not seem to be any change in the bimodal seasonality of varicella, which goes back additional years. This means that scarlet fever epidemics did not have a significant impact on varicella rates.
Discussion
The Hong Kong data captures one of the rare times in history when scarlet fever epidemics arose during a period of ongoing annual varicella cycles. From this analysis one can reject the hypothesis that the association of the two diseases resulted from the influence of scarlet fever on varicella. It seems more likely that varicella influenced the timing and number of scarlet fever cases. But to go further in explaining the connection between the diseases would require data at the individual level.
One might ask whether the lack of routine childhood vaccination for varicella contributed in part to the return of scarlet fever. In the years of this analysis Hong Kong did not routinely vaccinate children for varicella, but in 2013 Hong Kong adopted a plan for vaccination in two doses with the first at age one. The plan did not, however, include catching up older children on vaccinations. 8 The new vaccination program is unlikely to have affected this analysis, however, because varicella usually affects children over the age of three. In China, vaccination for varicella is optional and often only uses one dose, limiting its effectiveness. 9 A practical question is whether a higher vaccination rate for varicella would inhibit scarlet fever epidemics in Hong Kong and other countries, such as the UK and China, that do not require varicella vaccination. 
